KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Align Technology (ALGN) EBT (2016 - 2025)

Historic EBT for Align Technology (ALGN) over the last 17 years, with Q3 2025 value amounting to $94.7 million.

  • Align Technology's EBT fell 4290.73% to $94.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $549.5 million, marking a year-over-year decrease of 1428.77%. This contributed to the annual value of $609.0 million for FY2024, which is 502.88% down from last year.
  • According to the latest figures from Q3 2025, Align Technology's EBT is $94.7 million, which was down 4290.73% from $173.5 million recorded in Q2 2025.
  • In the past 5 years, Align Technology's EBT ranged from a high of $268.8 million in Q2 2021 and a low of $94.7 million during Q3 2025
  • For the 5-year period, Align Technology's EBT averaged around $172.1 million, with its median value being $165.9 million (2024).
  • In the last 5 years, Align Technology's EBT soared by 46575.18% in 2021 and then crashed by 5318.83% in 2022.
  • Over the past 5 years, Align Technology's EBT (Quarter) stood at $220.0 million in 2021, then tumbled by 47.58% to $115.3 million in 2022, then surged by 49.91% to $172.9 million in 2023, then dropped by 18.57% to $140.8 million in 2024, then plummeted by 32.71% to $94.7 million in 2025.
  • Its EBT stands at $94.7 million for Q3 2025, versus $173.5 million for Q2 2025 and $140.4 million for Q1 2025.